Phosphorylated Peptides Are Naturally Processed and Presented by Major Histocompatibility Complex Class I Molecules in Vivo
Open Access
- 18 December 2000
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 192 (12) , 1755-1762
- https://doi.org/10.1084/jem.192.12.1755
Abstract
Posttranslational modification of peptide antigens has been shown to alter the ability of T cells to recognize major histocompatibility complex (MHC) class I–restricted peptides. However, the existence and origin of naturally processed phosphorylated peptides presented by MHC class I molecules have not been explored. By using mass spectrometry, significant numbers of naturally processed phosphorylated peptides were detected in association with several human MHC class I molecules. In addition, CD8+ T cells could be generated that specifically recognized a phosphorylated epitope. Thus, phosphorylated peptides are part of the repertoire of antigens available for recognition by T cells in vivo.Keywords
This publication has 58 references indexed in Scilit:
- Protein tyrosine kinases: Structure, substrate specificity, and drug discoveryBiopolymers, 1998
- An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.The Journal of Experimental Medicine, 1996
- Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum.The Journal of Experimental Medicine, 1995
- The Biochemistry and Cell Biology of Antigen Processing and PresentationAnnual Review of Immunology, 1993
- Consensus motifs and peptide ligands of MHC class I moleculesSeminars in Immunology, 1993
- HLA-A2.1-Associated Peptides from a Mutant Cell Line: A Second Pathway of Antigen PresentationScience, 1992
- Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass SpectrometryScience, 1992
- Cooperation between oncogenesCell, 1991
- Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodiesTissue Antigens, 1983
- Partial purification and some properties of BB7.2 a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28Human Immunology, 1981